Showing results (201-210 of 831) with videos related to

Sort By:
Pageof 84
Advances in Therapy|October 7, 2017
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical ExperienceGilles Salles, Martin Barrett, Robin Foà, et al.
Cancer|June 16, 2004
Granulocyte-colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemiaAlfonso Quintas-Cardama, Hagop Kantarjian, Susan O'Brien, et al.
Cancer|May 26, 2004
Erythropoietin is effective in improving the anemia induced by imatinib mesylate therapy in patients with chronic myeloid leukemia in chronic phaseJorge Cortes, Susan O'Brien, Alfonso Quintas, et al.
Leukemia Research|July 1, 2008
Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximabClive S Zent, Charla R Secreto, Betsy R LaPlant, et al.
Blood|September 25, 2004
Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabineTait D Shanafelt, Yean K Lee, Nancy D Bone, et al.
Cancer|December 18, 2008
Validation of a new prognostic index for patients with chronic lymphocytic leukemiaTait D Shanafelt, Greg Jenkins, Timothy G Call, et al.
Leukemia & Lymphoma|March 23, 2010
Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisoneDeborah A Bowen, Timothy G Call, Tait D Shanafelt, et al.
Leukemia & Lymphoma|May 26, 2010
Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemiaTait D Shanafelt, Kari G Rabe, Neil E Kay, et al.
Molecular Cancer Therapeutics|September 21, 2006
Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathwaysChunrong Yu, Bret B Friday, Jin-Ping Lai, et al.
Mayo Clinic Proceedings|April 10, 2007
Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic testGrzegorz S Nowakowski, James D Hoyer, Tait D Shanafelt, et al.
Pageof 84